Google+ Facebook Twitter Twitter

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

breast cancer cells - CREDIT - Science Photo Library-c0559159

While chemotherapy aims to eliminate all cancer cells, some of them may evade treatment and survive, resulting in recurrence of the cancer.

In a study that spanned over 10 years, Research Assistant Professor Leong Sai Mun from the National University of Singapore Centre for Cancer Research and his research team sought to uncover the reasons for why some breast cancer tumours survive chemotherapy.

In examining tumour and blood samples from 63 patients with breast cancer across different stages, as well as lab-grown breast cancer cells and laboratory models, the team found that cancer cells with high expression of the small non-coding RNA miR-125b cooperate with surrounding cancer cells to allow the latter to grow and resist chemotherapy.

Contrary to the belief that cancer cells are self-serving and driven by survival, this breakthrough study indicates that they display altruistic behaviour to help other cancer cells thrive by sacrificing their own abilities to multiply.

The authors claim that reveals that disrupting such cooperation could be key to developing more effective treatments.

Leong said: “Our research has identified these cooperative behaviours between cancer cells, which treatment must target specifically for them to be destroyed more effectively. ”

Image credit | Science Photo Library

Related Articles

Specialist diploma in molecular pathology

On behalf of the members of the Molecular Pathology Advisory Panel, Chair Dr Andrew Blann introduces the new Specialist Diploma.

The role of organelle repair in fighting infection

Research has found that cellular structures act as “molecular plasters” that protect against infections, such as tuberculosis. We talk to study co-author Claudio Bussi.

Early-stage stem cell therapy trial

An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.